Report Detail
Global Antidote Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4715197 |
- 29 June, 2026 |
- Global |
- 102 Pages |
- GIR |
- Consumer Goods
According to our (Global Info Research) latest study, the global Antidote market size was valued at US$ 9448 million in 2025 and is forecast to a readjusted size of US$ 11610 million by 2032 with a CAGR of 3.0% during review period.
Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.
Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.
In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.
This report is a detailed and comprehensive analysis for global Antidote market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antidote market size and forecasts, in consumption value ($ Million), 2021-2032
Global Antidote market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antidote market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Antidote market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antidote
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antidote market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Bayer, Johnson & Johnson, Novartis, Eli Lilly, Teva, Boehringer Ingelheim, Mylan, Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antidote market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes
Market segment by Application
Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others
Market segment by players, this report covers
Roche
Pfizer
Bayer
Johnson & Johnson
Novartis
Eli Lilly
Teva
Boehringer Ingelheim
Mylan
Fresenius Kabi
Baxter
Furen Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antidote product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antidote, with revenue, gross margin, and global market share of Antidote from 2021 to 2026.
Chapter 3, the Antidote competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antidote market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antidote.
Chapter 13, to describe Antidote research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Antidote by Type
- 1.3.1 Overview: Global Antidote Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Antidote Consumption Value Market Share by Type in 2025
- 1.3.3 Chemical Antidotes
- 1.3.4 Physical Antidotes
- 1.3.5 Pharmacological Antidotes
- 1.4 Global Antidote Market by Application
- 1.4.1 Overview: Global Antidote Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pesticide Poisoning
- 1.4.3 Heavy Metal Poisoning
- 1.4.4 Animal Bites Poisoning
- 1.4.5 Cyanide Poisoning
- 1.4.6 Others
- 1.5 Global Antidote Market Size & Forecast
- 1.6 Global Antidote Market Size and Forecast by Region
- 1.6.1 Global Antidote Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Antidote Market Size by Region, (2021-2032)
- 1.6.3 North America Antidote Market Size and Prospect (2021-2032)
- 1.6.4 Europe Antidote Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Antidote Market Size and Prospect (2021-2032)
- 1.6.6 South America Antidote Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Antidote Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Antidote Product and Solutions
- 2.1.4 Roche Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments and Future Plans
- 2.2 Pfizer
- 2.2.1 Pfizer Details
- 2.2.2 Pfizer Major Business
- 2.2.3 Pfizer Antidote Product and Solutions
- 2.2.4 Pfizer Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Pfizer Recent Developments and Future Plans
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Antidote Product and Solutions
- 2.3.4 Bayer Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Bayer Recent Developments and Future Plans
- 2.4 Johnson & Johnson
- 2.4.1 Johnson & Johnson Details
- 2.4.2 Johnson & Johnson Major Business
- 2.4.3 Johnson & Johnson Antidote Product and Solutions
- 2.4.4 Johnson & Johnson Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Johnson & Johnson Recent Developments and Future Plans
- 2.5 Novartis
- 2.5.1 Novartis Details
- 2.5.2 Novartis Major Business
- 2.5.3 Novartis Antidote Product and Solutions
- 2.5.4 Novartis Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Novartis Recent Developments and Future Plans
- 2.6 Eli Lilly
- 2.6.1 Eli Lilly Details
- 2.6.2 Eli Lilly Major Business
- 2.6.3 Eli Lilly Antidote Product and Solutions
- 2.6.4 Eli Lilly Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Eli Lilly Recent Developments and Future Plans
- 2.7 Teva
- 2.7.1 Teva Details
- 2.7.2 Teva Major Business
- 2.7.3 Teva Antidote Product and Solutions
- 2.7.4 Teva Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Teva Recent Developments and Future Plans
- 2.8 Boehringer Ingelheim
- 2.8.1 Boehringer Ingelheim Details
- 2.8.2 Boehringer Ingelheim Major Business
- 2.8.3 Boehringer Ingelheim Antidote Product and Solutions
- 2.8.4 Boehringer Ingelheim Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
- 2.9 Mylan
- 2.9.1 Mylan Details
- 2.9.2 Mylan Major Business
- 2.9.3 Mylan Antidote Product and Solutions
- 2.9.4 Mylan Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Mylan Recent Developments and Future Plans
- 2.10 Fresenius Kabi
- 2.10.1 Fresenius Kabi Details
- 2.10.2 Fresenius Kabi Major Business
- 2.10.3 Fresenius Kabi Antidote Product and Solutions
- 2.10.4 Fresenius Kabi Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Fresenius Kabi Recent Developments and Future Plans
- 2.11 Baxter
- 2.11.1 Baxter Details
- 2.11.2 Baxter Major Business
- 2.11.3 Baxter Antidote Product and Solutions
- 2.11.4 Baxter Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Baxter Recent Developments and Future Plans
- 2.12 Furen Pharmaceutical
- 2.12.1 Furen Pharmaceutical Details
- 2.12.2 Furen Pharmaceutical Major Business
- 2.12.3 Furen Pharmaceutical Antidote Product and Solutions
- 2.12.4 Furen Pharmaceutical Antidote Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Furen Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Antidote Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Antidote by Company Revenue
- 3.2.2 Top 3 Antidote Players Market Share in 2025
- 3.2.3 Top 6 Antidote Players Market Share in 2025
- 3.3 Antidote Market: Overall Company Footprint Analysis
- 3.3.1 Antidote Market: Region Footprint
- 3.3.2 Antidote Market: Company Product Type Footprint
- 3.3.3 Antidote Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Antidote Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Antidote Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Antidote Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Antidote Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Antidote Consumption Value by Type (2021-2032)
- 6.2 North America Antidote Market Size by Application (2021-2032)
- 6.3 North America Antidote Market Size by Country
- 6.3.1 North America Antidote Consumption Value by Country (2021-2032)
- 6.3.2 United States Antidote Market Size and Forecast (2021-2032)
- 6.3.3 Canada Antidote Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Antidote Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Antidote Consumption Value by Type (2021-2032)
- 7.2 Europe Antidote Consumption Value by Application (2021-2032)
- 7.3 Europe Antidote Market Size by Country
- 7.3.1 Europe Antidote Consumption Value by Country (2021-2032)
- 7.3.2 Germany Antidote Market Size and Forecast (2021-2032)
- 7.3.3 France Antidote Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Antidote Market Size and Forecast (2021-2032)
- 7.3.5 Russia Antidote Market Size and Forecast (2021-2032)
- 7.3.6 Italy Antidote Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Antidote Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Antidote Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Antidote Market Size by Region
- 8.3.1 Asia-Pacific Antidote Consumption Value by Region (2021-2032)
- 8.3.2 China Antidote Market Size and Forecast (2021-2032)
- 8.3.3 Japan Antidote Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Antidote Market Size and Forecast (2021-2032)
- 8.3.5 India Antidote Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Antidote Market Size and Forecast (2021-2032)
- 8.3.7 Australia Antidote Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Antidote Consumption Value by Type (2021-2032)
- 9.2 South America Antidote Consumption Value by Application (2021-2032)
- 9.3 South America Antidote Market Size by Country
- 9.3.1 South America Antidote Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Antidote Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Antidote Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Antidote Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Antidote Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Antidote Market Size by Country
- 10.3.1 Middle East & Africa Antidote Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Antidote Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Antidote Market Size and Forecast (2021-2032)
- 10.3.4 UAE Antidote Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Antidote Market Drivers
- 11.2 Antidote Market Restraints
- 11.3 Antidote Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Antidote Industry Chain
- 12.2 Antidote Upstream Analysis
- 12.3 Antidote Midstream Analysis
- 12.4 Antidote Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Antidote. Industry analysis & Market Report on Antidote is a syndicated market report, published as Global Antidote Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Antidote market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
